Nalaganje...
Bortezomib and etoposide combinations exert synergistic effects on the human prostate cancer cell line PC-3
Novel treatment modalities are urgently required for androgen-independent prostate cancer. In order to develop an alternative treatment for prostate cancer, the cytotoxic effects of the 26S proteasome inhibitor bortezomib, either alone or in combination with the two commonly used chemotherapeutic ag...
Shranjeno v:
| izdano v: | Oncol Lett |
|---|---|
| Main Authors: | , |
| Format: | Artigo |
| Jezik: | Inglês |
| Izdano: |
D.A. Spandidos
2016
|
| Teme: | |
| Online dostop: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4841005/ https://ncbi.nlm.nih.gov/pubmed/27123085 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3892/ol.2016.4340 |
| Oznake: |
Označite
Brez oznak, prvi označite!
|